Current recommendations for revascularization of non-infarct-related artery in patients presenting with ST-segment elevation myocardial infarction and multivessel disease

被引:2
|
作者
Towashiraporn, Korakoth [1 ]
机构
[1] Mahidol Univ, Fac Med Siriraj Hosp, Her Majesty Cardiac Ctr, Bangkok, Thailand
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词
ST-segment elevation myocardial infarction; multivessel disease; complete revascularization; percutaneous coronary intervention; infarct-related artery; PERCUTANEOUS CORONARY INTERVENTION; LESION-ONLY REVASCULARIZATION; CARDIOGENIC-SHOCK; SCIENTIFIC STATEMENT; RANDOMIZED-TRIAL; CULPRIT LESION; MANAGEMENT; PLAQUE; STEMI; OUTCOMES;
D O I
10.3389/fcvm.2022.969060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality worldwide. Immediate reperfusion therapy of the infarct-related artery (IRA) is the mainstay of treatment, either via primary percutaneous coronary intervention (PPCI) or thrombolytic therapy when PPCI is not feasible. Several studies have reported the incidence of multivessel disease (MVD) to be about 50% of total STEMI cases. This means that after successful PPCI of the IRA, residual lesion(s) of the non-IRA may persist. Unlike the atherosclerotic plaque of stable coronary artery disease, the residual obstructive lesion of the non-IRA contains a significantly higher prevalence of vulnerable plaques. Since these lesions are a strong predictor of acute coronary syndrome, if left untreated they are a possible cause of future adverse cardiovascular events. Percutaneous coronary intervention (PCI) of the obstructive lesion of the non-IRA to achieve complete revascularization (CR) is therefore preferable. Several major randomized controlled trials (RCTs) and meta-analyses demonstrated the clinical benefits of the CR strategy in the setting of STEMI with MVD, not only for enhancing survival but also for reducing unplanned revascularization. The CR strategy is now supported by recently published clinical practice guidelines. Nevertheless, the benefit of revascularization must be weighed against the risks from additional procedures.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Non-infarct related artery revascularization in ST-segment elevation myocardial infarction patients with multivessel disease
    Cheema, Asim N.
    Mehta, Shamir R.
    Verma, Subodh
    Bagai, Akshay
    CURRENT OPINION IN CARDIOLOGY, 2017, 32 (05) : 600 - 607
  • [2] Optional Revascularization Strategies for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
    Zhong, Peng-Yu
    Sun, Bin
    Cao, Hai -Ping
    Wang, Wei
    Xiong, Ting-Lin
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (06)
  • [3] Benefit of Revascularization in Non-Infarct-Related Artery in Multivessel Disease Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Chen, Huang-Chung
    Tsai, Tzu-Hsien
    Fang, Hsiu-Yu
    Sun, Cheuk-Kwan
    Lin, Yu-Chun
    Leu, Steve
    Chung, Sheng-Ying
    Chai, Han-Tan
    Yang, Cheng-Hsu
    Hsien, Yuan-Kai
    Wu, Chiung-Jen
    Yip, Hon-Kan
    INTERNATIONAL HEART JOURNAL, 2010, 51 (05) : 319 - 324
  • [4] Timing and modality of complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel coronary artery disease
    Benatti, Giorgio
    Gragnano, Felice
    Vignali, Luigi
    Calabro, Paolo
    Gurgoglione, Filippo Luca
    Niccoli, Giampaolo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 380 : 6 - 11
  • [5] Comparison of Approaches to Revascularization in Patients With Multivessel Coronary Artery Disease Presenting With ST-Segment Elevation Myocardial Infarction: Meta-analyses of Randomized Control Trials
    Bajaj, Navkaranbir S.
    Kalra, Rajat
    Aggarwal, Himanshu
    Ather, Sameer
    Gaba, Saurabh
    Arora, Garima
    McGiffin, David C.
    Ahmed, Mustafa
    Aslibekyan, Stella
    Arora, Pankaj
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (12):
  • [6] Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction With Cardiogenic Shock
    Lee, Joo Myung
    Rhee, Tae-Min
    Hahn, Joo-Yong
    Kim, Hyun Kuk
    Park, Jonghanne
    Hwang, Doyeon
    Choi, Ki Hong
    Kim, Jihoon
    Park, Taek Kyu
    Yang, Jeong Hoon
    Bin Song, Young
    Choi, Jin-Ho
    Choi, Seung-Hyuk
    Koo, Bon-Kwon
    Kim, Young Jo
    Chae, Shung Chull
    Cho, Myeong Chan
    Kim, Chong Jin
    Gwon, Hyeon-Cheol
    Kim, Ju Han
    Kim, Hyo-Soo
    Jeong, Myung Ho
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (08) : 844 - 856
  • [7] Optimal Strategy for Complete Revascularization in ST-Segment Elevation Myocardial Infarction and Multivessel Disease
    Ueyama, Hiroki A.
    Akita, Keitaro
    Kiyohara, Yuko
    Takagi, Hisato
    Briasoulis, Alexandros
    Wiley, Jose
    Bangalore, Sripal
    Mehran, Roxana
    Stone, Gregg W.
    Kuno, Toshiki
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (01) : 19 - 38
  • [8] Nomogram to Predict Outcomes After Staged Revascularization in ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease
    Wang, Huaigen
    Ma, Aiqun
    Wang, Tingzhong
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 1713 - 1722
  • [9] Current Status of Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease
    Kim, Min Chul
    Jeong, Myung Ho
    Kim, Sang Hyung
    Hong, Young Joon
    Kim, Ju Han
    Ahn, Youngkeun
    KOREAN CIRCULATION JOURNAL, 2014, 44 (03) : 131 - 138
  • [10] Comparative Effectiveness of Complete Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Bayesian Network Meta-Analysis
    Zhao, Lingyue
    Guo, Wenqin
    Huang, Weichao
    Wang, Lili
    Mo, Fanrui
    Chen, Xiehui
    Li, Chaoyang
    Huang, Siquan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8